Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BFS Molecular
Italy
- Ownership
- Private
- Development stage
- Other
01
Overview
BFS Molecular was a software and algorithm development company focused on next-generation sequencing (NGS)-based solutions for transplant patient monitoring. Its technology was integrated into CareDx’s transplant surveillance products, including AlloSeq cfDNA and AlloSeq HCT, after its acquisition. There is no publicly available evidence of clinical trials under BFS Molecular’s independent name; its platforms are used as diagnostic/prognostic tools rather than therapeutic interventions.
- Therapeutic areas
- Immunology
- Modalities
- Sequencing assayBioinformatics platform
- Industry
- Molecular Diagnostics
02
Partnerships
You Do Bio (distribution agreement for post-transplant monitoring solutions)
Beyond the preview
Go deeper on BFS Molecular.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BFS Molecular.